Literature DB >> 18458869

IL-6 and metabolism-new evidence and new questions.

A Krook1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18458869     DOI： 10.1007/s00125-008-1019-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  18 in total

Review 1.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

2.  Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes.

Authors:  T Kanemaki; H Kitade; M Kaibori; K Sakitani; Y Hiramatsu; Y Kamiyama; S Ito; T Okumura
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

3.  Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle.

Authors:  Charlotte Keller; Adam Steensberg; Anne K Hansen; Christian P Fischer; Peter Plomgaard; Bente Klarlund Pedersen
Journal:  J Appl Physiol (1985)       Date:  2005-08-11

4.  Interleukin-6 induces cellular insulin resistance in hepatocytes.

Authors:  Joseph J Senn; Peter J Klover; Irena A Nowak; Robert A Mooney
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

5.  Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.

Authors:  Andrew L Carey; Gregory R Steinberg; S Lance Macaulay; Walter G Thomas; Anna G Holmes; Georg Ramm; Oja Prelovsek; Cordula Hohnen-Behrens; Matthew J Watt; David E James; Bruce E Kemp; Bente K Pedersen; Mark A Febbraio
Journal:  Diabetes       Date:  2006-10       Impact factor: 9.461

6.  Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes.

Authors:  J M Stouthard; R P Oude Elferink; H P Sauerwein
Journal:  Biochem Biophys Res Commun       Date:  1996-03-18       Impact factor: 3.575

Review 7.  IL-6 signalling in exercise and disease.

Authors:  B K Pedersen
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

Review 8.  Role of interleukin-6 signalling in glucose and lipid metabolism.

Authors:  S Glund; A Krook
Journal:  Acta Physiol (Oxf)       Date:  2008-01       Impact factor: 6.311

9.  Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice.

Authors:  S Franckhauser; I Elias; V Rotter Sopasakis; T Ferré; I Nagaev; C X Andersson; J Agudo; J Ruberte; F Bosch; U Smith
Journal:  Diabetologia       Date:  2008-04-24       Impact factor: 10.122

10.  Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects.

Authors:  Victoria Rotter; Ivan Nagaev; Ulf Smith
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157
View more
  4 in total

1.  FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy.

Authors:  Sergei Y Funikov; Alexander P Rezvykh; Pavel V Mazin; Alexey V Morozov; Andrey V Maltsev; Maria M Chicheva; Ekaterina A Vikhareva; Mikhail B Evgen'ev; Aleksey A Ustyugov
Journal:  Neurogenetics       Date:  2018-07-07       Impact factor: 2.660

2.  Silver nanoparticle-enhanced fluorescence in microtransponder-based immuno- and DNA hybridization assays.

Authors:  Ji Li; Zhuying Wang; Ignacy Gryczynski; Wlodek Mandecki
Journal:  Anal Bioanal Chem       Date:  2010-08-27       Impact factor: 4.142

Review 3.  Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases.

Authors:  Ying-Shuang Li; Hua-Cheng Ren; Jian-Hua Cao
Journal:  Int Immunopharmacol       Date:  2022-06-28       Impact factor: 5.714

4.  Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans.

Authors:  S Gregersen; D Samocha-Bonet; L K Heilbronn; L V Campbell
Journal:  J Nutr Metab       Date:  2012-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.